血管紧张素转换酶抑制剂

常规治疗组32例，接受血管紧张素转换酶抑制剂（ACEI）、β受体阻滞剂、抗血小板等常规药物治疗。

Convention group [ 32 patients , ages ( 63 ± 11 ) years , 22 males ] received angiotensin converting enzyme inhibitor ( ACEI ), β blocker and anti plaque agent .

既往研究表明，血管紧张素转换酶抑制剂（ACEI）等药物可有效降压，预防和逆转心肌纤维化，其机制与影响肾素血管紧张素一醛固酮系统（RAAS）有关。

Some studies suggest that angiotensin converting enzyme inhibitor ( ACEI ) can decrease blood pressure effectively , prevent and reverse myocardial fibrosis , the mechanism of which is related to the influence on the rennin-angiotensin - aldosterone system ( RAAS ) .

高血压患者血清Ⅲ型前胶原N端肽的变化及血管紧张素转换酶抑制剂对其影响

Effect of angiotensin-converting enzyme inhibitor on serum aminoterminal propeptide of type ⅲ procollagen in hypertensive patients

B组为对照组，予除血管紧张素转换酶抑制剂以外的其他药物控制血压，并予口服药物降糖。

The compared group ( group B ) were treated with conventional treatment except ACEI to control blood pressure .

RP-HPLC检测血管紧张素转换酶抑制剂活性的浓度

Study on the Angiotensin-I Converting Enzyme Inhibitory Activity by RP-HPLC

尿激酶联合血管紧张素转换酶抑制剂治疗IgA肾病的随访观察

Follow-up of the Effect on the Urokinase Combined with Angiotensin Converting Enzyme Inhibitor on IgA Nephropathy

所有病人都得到最佳的药物治疗包括p他洛克阻滞剂，血管紧张素转换酶抑制剂，血管紧张素受体拮抗剂，螺内酯，利尿剂等。

At the time of CRT device implantation , all patients were receiving optimal medications , including beta-blockers , angiotensin-converting enzyme inhibitors or angiotensin receptor blockers , spironolactone , and loop diuretics .

β-受体阻滞剂、血管紧张素转换酶抑制剂与血管紧张素受体拮抗剂及醛固酮受体拮抗剂可降低DCM心力衰竭的死亡率。

Betablocker , ACE inhibitor , angiotensin receptor blocker and aldosterone blocker are efficient in reducing mortality .

卡托普利（captopril），又名巯甲丙脯酸，是一种血管紧张素转换酶抑制剂，是治疗高血压及充血性心衰的首选药物之一。

Captopril , an angiotensin-converting enzyme inhibitor , has been widely used to treat hypertension and congestive heart failure .

目的建立狗急性心肌缺血模型，观察不同血管紧张素转换酶抑制剂（ACEI）对血管紧张素转换酶（ACE）活性、冠状动脉侧支循环形成的影响。

Objective To observe the effects of different angiotensin converting enzyme inhibitors ( ACEI ) on coronary collateral circulation .

目的：研究血管紧张素转换酶抑制剂（ACE抑制剂）治疗高血压的咳嗽发生率和停药率。

Objective : To study the prevalence of cough and withdrawal of angiotensin converting enzyme inhibitors ( ACEI ) in treatment of hypertension .

目的：血管紧张素转换酶抑制剂（ACEI）是治疗充血性心力衰竭（CHF）的重要药物。

Objective : Angiotensin-converting-enzyme inhibitor ( ACEI ) is an important therapy to congestive heart failure ( CHF ) .

目的评价在常规药物洋地黄、利尿剂、血管紧张素转换酶抑制剂（ACEI）及β受体阻滞剂治疗充血性心力衰竭（CHF）α1受体阻滞乌拉地尔的临床疗效比较。

Objective To assess the clinical curative effect in digitalis , diuretics , ACEI and β - receptor blocker in treatment of CHF .

当Sink在维克森林大学的同事发现药物可以保护大鼠免受辐射造成的脑损伤后，她决定研究有中枢作用的血管紧张素转换酶抑制剂类药物对痴呆症风险的影响。

Sink decided to investigate the effect of centrally acting ACE inhibitors on dementia risk after her Wake Forest colleagues found the drugs protected rats from brain injury due to radiation .

目的评价复方甘草片对血管紧张素转换酶抑制剂（ACEI）性咳嗽的临床疗效。

Objective To evaluate the clinical therapeutic effect of the Tab Glycyrrhiza Compound on Angiotensin-converting Enzyme Inhibitors ( ACEI ) cough .

结论：从病理生理的角度看血管紧张素转换酶抑制剂（ACEI）对于治疗先天性心脏病肺动脉高压有确切的作用，但这一作用是有限的。

Conclusions : The effect of ACEI in the treatment of congenital heart disease children with pulmonary hypertension is affirmative but determinatus .

结论：血管紧张素转换酶抑制剂（ACEI）类药物被证实为目前最有效的逆转LVH药物。

Conclusion : Angiotensin converting enzyme Inhibitors ( ACEI ) Was proved to be the most effective drug to set back LVH .

目的分析血管紧张素转换酶抑制剂（ACEI）与安体舒通在联合治疗心力衰竭（心衰）或高血压等疾病中发生严重高钾血症的危险因素和发生率。

Objective To analyze risk factors and morbidity of serious hyperkalemia during combined treatment with angiotensin-converting enzyme inhibitors ( ACEI ) and spironolactone .

目的考察合并高血压的非昏迷老年脑卒中患者应用血管紧张素转换酶抑制剂（ACEI）类降压药对其并发症肺炎的发生是否具有抑制作用。

Objective To investigate the effects of angiotensin-converting-enzyme inhibitor ( ACEI ) on the pneumonia in older stroke patients with hypertension and no coma .

ARB可改善纤溶参数，但血管紧张素转换酶抑制剂未见此作用。

Treatment with ARB can correct the abnormalities of plasma fibrinolytic parameters , however the addition of ACEI is not effective .

目的：研究阿司匹林和血管紧张素转换酶抑制剂（ACEI）联合使用对急性心肌梗塞（AMI）患者病死率的影响。

Objective : This study was to evaluate the clinical effects of angiotensin converting enzyme inhibitors ( ACEI ) with aspirin treatment for acute myocardial infarction ( AMI ) .

背景：目前血管紧张素转换酶抑制剂（angiotensin-convertingenzymeinhibitorACEI）类药物广泛应用治疗心脑血管疾病，如高血压、冠心病、心力衰竭、脑卒中等。

Objective : Angiotensin-converting enzyme inhibitor ( ACEI ) have been widely managing cardiovascular disease and cerebrovascular disease , example for hypertension , coronary arterial disease , congestive heart failure and cerebral apoplexy .

目的：观察大剂量黄芪联合血管紧张素转换酶抑制剂（ACEI）治疗肾性蛋白尿的疗效。

Objective : To observe the effects of the high dosage of Astragalus Injection united with the Angiotensin Converting Enzyme Inhibitor ( ACEI ) on patients with nephrogenous albuminuria .

QT间期离散度对急性心肌梗塞的预后具有重要价值，血管紧张素转换酶抑制剂（ACEI）对缺血心肌具有保护作用，但ACEI是否影响QT间期离散度？

QT dispersion is a important prognostic factor for acute myocardial infarction . ACEI has protective effect on ischemic myocardium but the question is whether it affects QT dispersion in myocardial infarction .

用PCR方法检测ACE基因第16内含子的插入/缺失（insertion/deletion，I/D）多态性，比较血管紧张素转换酶抑制剂治疗前后各基因型患者尿蛋白定量下降程度的差异。

The ACE gene insertion / deletion ( I / D ) polymorphisms in intron 16 were determined by PCR . A comparison of the reducing urinary protein efficacy of benazepril was made between the patients with different ACE genotypes .

心功能级别、病变部位、高血压、利尿剂、洋地黄制剂、硝酸酯类、血管紧张素转换酶抑制剂（ACEI）及β-阻滞剂对生存有影响。

The heart function , lesion site , hypertension and the treatment of diuretics , digitalis , nitride , ACEI and β - blocker had a significant influence on survival .

结论应用血管紧张素转换酶抑制剂（ACEI）治疗原发性高血压时，宜首选培哚普利。

Conclusion It is suggested that perindopril should be the first choice when angiotensin converting enzyme inhibitor ( ACEI ) is taken into account for the therapy of primary hypertension .

目的探讨缓激肽（BK）对大鼠心肌梗塞（MI）后心肌胶原生化改建的影响，以及血管紧张素转换酶抑制剂（ACEI）对心肌胶原的影响是否与抑制BK的降解有关。

Objective To investigate the effects of bradykinin ( BK ) on collagen from rat heart after myocardial infarction and the importance of BK in ACEI therapy in rats after myocardial infarction .

目的：按照循证医学标准，对国内外血管紧张素转换酶抑制剂（ACEI）所致咳嗽机制研究的结果予以总结和评价，指导临床工作。

Objective : To summarize and evaluate the current situation of clinical studies on cough mechanism induced by angiotensin converting enzyme inhibitors ( ACEI ) according to evidence based medicine standards .

药物治疗中，血管紧张素转换酶抑制剂（ACE-Ⅰ）及血管紧张素Ⅱ受体拮抗剂（ARB）总使用率为84.7%，β-受体阻滞剂使用率为60.0%（168例）。

Medical treatments included angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in 237 patients ( 84.7 % ) and beta-blockers in 168 ( 60.0 % ) .